ELA
Envela Corporation
ELA's fundamentals are strong: revenue grew 48% and its operating margin rose 4 points to 9.6%. At 12x earnings, it's trading below its usual 18x. Analysts expect earnings to fall sharply.
ELA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Healthy | |
| Strong |
ELA's revenue, profitability, cash flow and balance sheet are all currently healthy.
ELA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 12x | $10.14 | -2.4% |
| Current | 12x | $10.39 | — |
| Fair | 18x | $15.50 | +49% |
| Forward | 19x | $10.39 | — |
| Expensive | 30x | $25.09 | +141% |
Historical ranges are pointers, not guarantees.
ELA's PE is in its cheap range at 12x. Analysts expect earnings to fall, which would put today's price at 19x next year's earnings, in its fair range.
ELA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong decline | |
| Decline | |
| Weakening | |
| Limited | |
| Moderate |
Analysts expect ELA's earnings and revenue to decline, with profitability weakening.
ELA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.56 | -35% |
| Q2 2026 | $0.85 | +150% |
| Q1 2026 | $0.80 | +176% |
| Q4 2025 | $0.56 | +115% |
| Q3 2025 | $0.41 | +64% |
| Q2 2025 | $0.34 | +36% |
| Q1 2025 | $0.29 | +16% |
| Q4 2024 | $0.26 | -3.7% |
| Q3 2024 | $0.25 | -42% |
ELA earned $0.85 per share over the past year, up 150% from the year before.
ELA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $56.8M | +3.5% |
| Q1 2026 | $98.4M | +104% |
| Q4 2025 | $80.5M | +67% |
| Q3 2025 | $57.4M | +22% |
| Q2 2025 | $54.9M | +21% |
| Q1 2025 | $48.3M | +21% |
| Q4 2024 | $48.3M | +32% |
| Q3 2024 | $46.9M | +29% |
ELA's revenue has grown year over year for eight quarters in a row: $57M last quarter, up 3.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 9% | +3.1 points |
| Q1 2026 | 11% | +4.9 points |
| Q4 2025 | 9.4% | +5.4 points |
| Q3 2025 | 7.3% | +3 points |
| Q2 2025 | 5.9% | +1.7 points |
| Q1 2025 | 6.5% | +0.6 points |
| Q4 2024 | 3.9% | -0.4 points |
| Q3 2024 | 4.3% | -1.1 points |
ELA's operating margin was 9% last quarter, up 3.1 points from the same quarter a year ago.
ELA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $5M | +137% |
| Q1 2026 | $20.6M | +2658% |
| Q4 2025 | -$3.7M | -215% |
| Q3 2025 | $2.2M | +51% |
| Q2 2025 | $2.1M | +$3.4M |
| Q1 2025 | $746.6K | -78% |
| Q4 2024 | $3.2M | +91% |
| Q3 2024 | $1.5M | +172% |
ELA generated $24M in free cash flow over the past year, about three times what it generated the year before.
ELA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | -0.1% | -28.5K shares |
| 3 years | -3.6% | -968K shares |
| 5 years | -3.6% | -976K shares |
| Available history | -3.6% | -961K shares |
ELA has 26M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | $67,582 |
| Q2 2025 | $118,700 |
| Q1 2025 | $2,626 |
| Q4 2024 | $64,779 |
| Q3 2024 | $728,510 |
| Q2 2024 | $715,339 |
ELA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -1.1x | Net Cash |
| Q1 2026 | -1.0x | Net Cash |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | -0.8x | Net Cash |
| Q2 2025 | -0.8x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -0.7x | Net Cash |
| Q3 2024 | -0.4x | Net Cash |
ELA has more cash than debt.
ELA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.8 | Oversold |
| Stochastic | 1.6 | Oversold |
ELA's weekly RSI is 30 (oversold) and its Stochastic is 2 (oversold).
ELA PE vs Consumer Cyclical Sector
| Metric | ELA | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 18x | 32% below |
| PE % | 20 | 47 | 27 pts below |
ELA is trading at 12x earnings, a 32% discount to the Consumer Cyclical sector's median of 18x.
ELA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.5 | 10% below |
| 20 week MA | $15.3 | 32% below |
| 50 week MA | $16.6 | 37% below |
| 100 week MA | $11.8 | 12% below |
| 200 week MA | $8.64 | 20% above |
ELA has fallen below most of its moving averages, though it's still 20% above its 200-week average.
ELA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.37 | $5.01 | +266% |
| 2021 | $5.01 | $4.10 | -18% |
| 2022 | $4.10 | $5.29 | +29% |
| 2023 | $5.29 | $4.86 | -8.1% |
| 2024 | $4.86 | $7.15 | +47% |
| 2025 | $7.15 | $12.5 | +75% |
| 2026 YTD | $12.5 | $10.4 | -17% |
ELA has finished higher in four of the last six years, two of them by more than 50%. It's down 17% so far in 2026.